Using the three principal sterilisation technologies of gamma,
electron beam and ethylene oxide, the Applied Sterilisation Technologies (AST)
business operates through a network of 28 sites in 11 countries
across Europe, Asia and Africa. Our services are widely used for
sterilising single use medical devices, pharmaceuticals, veterinary
and labware products in addition to controlling contamination in
cosmetics, packaging and food. Alongside the principal
technologies, this business also incorporates an Ion beam providing
a range of services such as material modification for a variety of
industrial sectors.
The AST business originated with the acquisition of
Isotron in 2007 and has since become a global service
provider with further acquisitions of GSP, BeamOne (now Synergy Health
Americas) and SterilGamma.